All In Biotech

Drug Trial Radar · NCT06962956

Evaluating Gingivitis and Systemic Biomarkers

An Exploratory Study to Evaluate the Relationship Between Gingivitis and Systemic Biomarkers

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 135 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

135

Actual

Start

Apr 30, 2025

Primary completion

Oct 31, 2025

Study completion Oct 31, 2025

Sponsor

Lead sponsor
Procter and GambleIndustry
Sponsor type
Industry
First posted
May 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (investigator, outcomes assessor)
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 25 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This exploratory study will consist of two parts: Phase 1 (sample collection/screening) and Phase 2 (sample collection/product efficacy testing). The purpose of Phase 1 is to understand the association of gingivitis to systemic biomarkers and to screen subjects for Phase 2. The purpose of Phase 2 is to assess the causal effect of oral hygiene intervention on gingivitis and systemic biomarkers.

Conditions

  • Gingivitis

Interventions

  • 0.76% Sodium Monofluorophosphate DentifriceDrug

    Brush two times a day for 1 minute with manual toothbrush

  • 0.454% Stannous Fluoride DentifriceDrug

    Brush two times a day for 1 minute with manual toothbrush

  • 0.454% Stannous Fluoride DentifriceDrug

    Brush two times a day for 2 minutes with electric toothbrush

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number Bleeding SitesTime frame: 4 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Salus Research

    Fort Wayne, Indiana

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.